Gena Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Kolkata, West Bengal, India, established in 2004.
2004 Kolkata, West Bengal, India Under Liquidation
Last Updated:
Access Report
About Gena Pharmaceuticals Limited

Gena Pharmaceuticals Limited, a under liquidation public limited company, was established on 11 May 2004 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239WB2004PLC098504. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.87 Cr.

It upholds a active non-compliant status. Employing 32 professional, Its leadership includes Suresh Kumar Sharma (Additional Director), Arabind Kumar Mishra (Additional Director), Vijaykumar Kanoria (Director). Past directors included Raj Kamal Kanoria, Vijaykumar Kanoria, Govind Prasad Kanoria. It holds ₹32.29 Cr open charges and ₹11.54 Cr settled loans. Its latest AGM occurred on 28 December 2020, with the balance sheet filed on 31 March 2020. It is based at 7/2/1, Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, 700128.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239WB2004PLC098504

  • Registration Number

    098504

  • Incorporation Date

    11 May 2004

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.87 Cr

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.87 Cr
  • Company Age 21 Year, 9 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 32.29 Cr
  • Satisfied Charges ₹ 11.54 Cr
  • Revenue Growth **** -29.58%
  • Profit Growth **** 22.30%
  • Ebitda **** -44.82%
  • Net Worth -1.13%
  • Total Assets -12.39%
Company report

Gena Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gena Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gena Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Suresh Kumar Sharma Additional Director 16 Dec 2022 Current
Arabind Kumar Mishra Additional Director 30 Sep 2011 Current
Vijaykumar Kanoria Director 23 May 2012 Current
Abhishek Kumar Shukla Additional Director 04 Jun 2019 Current
Santosh Kumar Sharma Additional Director 16 Dec 2022 Current
Rintu Bhattacharjee Additional Director 16 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 04 Jun 2019 Past
Pramod Abcsdd Director 30 Sep 2019 Past
Pramod Abcsdd Director 17 May 2012 Past
Pramod Abcsdd Additional Director 17 May 2012 Past
Pramod Abcsdd Additional Director 06 Mar 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gena Pharmaceuticals.

Gena Pharmaceuticals Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.58% decrease. The company also saw a substantial improvement in profitability, with a 22.3% increase in profit. The company's net worth dipped by a decrease of 1.13%.

Gena Pharmaceuticals revenue growth over time
Gena Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -29.58%
*******
*******
*******
*******
Revenue from Operations
*******
 -29.58%
*******
*******
*******
*******
Total Assets
*******
 -12.39%
*******
*******
*******
*******
Profit or Loss
*******
 22.30%
*******
*******
*******
*******
Net Worth
*******
 -1.13%
*******
*******
*******
*******
EBITDA
*******
 -44.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gena Pharmaceuticals?

In 2019, Gena Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹322,913,000.00

Satisfied Charges

₹115,380,000.00

Charges Breakdown by Lending Institutions
  • Edelweiss Asset Reconstruction Company Limited : 25.31 Cr
  • Andhra Bank : 6.98 Cr
Latest Charge Details
Date Lender Amount Status
04 Oct 2008 Edelweiss Asset Reconstruction Company Limited ₹12.66 Cr Open
28 Aug 2008 Edelweiss Asset Reconstruction Company Limited ₹12.66 Cr Open
03 Aug 2007 Andhra Bank ₹6.98 Cr Open
26 Oct 2004 United Bank Of India ₹11.54 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Gena Pharmaceuticals?

Gena Pharmaceuticals has a workforce of 32 employees as of Jan 15, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gena Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gena Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gena Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Suresh Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2022 & has been associated with this company since 3 years 2 months . was documented.

  • Director Appointment

    Progress on Santosh Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2022 & has been associated with this company since 3 years 2 months . was documented.

  • Director Appointment

    Progress on Rintu Bhattacharjee was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2022 & has been associated with this company since 3 years 2 months . was documented.

  • Annual General Meeting

    The activity Gena Pharmaceuticals Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records. was completed.

  • Balance Sheet

    Gena Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kolkata. was recorded as a recent event.

  • Director Appointment

    The activity Abhishek Kumar Shukla was appointed as a Additional Director was appointed as a Additional Director on 04 Jun 2019 & has been associated with this company since 6 years 8 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gena Pharmaceuticals Limited?

The CIN of Gena Pharmaceuticals Limited is U24239WB2004PLC098504.

Where is Gena Pharmaceuticals Limited headquartered?

Gena Pharmaceuticals Limited is headquartered at 7/2/1, Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, 700128.

When was Gena Pharmaceuticals Limited incorporated?

Gena Pharmaceuticals Limited was incorporated on 11 May 2004.

Who are the current directors of Gena Pharmaceuticals Limited?

The current directors of Gena Pharmaceuticals Limited are

What is the primary industry of Gena Pharmaceuticals Limited?

The primary industry of Gena Pharmaceuticals Limited is Manufacturing.

Is Gena Pharmaceuticals Limited a listed company?

Gena Pharmaceuticals Limited is unlisted.

What is the capital structure of Gena Pharmaceuticals Limited?

The authorized capital of Gena Pharmaceuticals Limited is ₹3.00 Cr, and the paid-up capital is ₹2.87 Cr.

What is the compliance status of Gena Pharmaceuticals Limited?

The compliance status of Gena Pharmaceuticals Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available